Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder.

@article{Geller2003WhichSA,
  title={Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder.},
  author={Daniel A. Geller and Joseph Biederman and S. Evelyn Stewart and Benjamin C. Mullin and Andr{\'e}s Martin and Thomas J. Spencer and Stephen V. Faraone},
  journal={The American journal of psychiatry},
  year={2003},
  volume={160 11},
  pages={
          1919-28
        }
}
OBJECTIVE The authors conducted a meta-analysis of published randomized, controlled medication trials in children and adolescents with obsessive-compulsive disorder (OCD) to assess evidence for differential efficacy based on type of drug, study design, and outcome measure. METHOD A systematic literature search was performed for articles pertaining to the pharmacological treatment of pediatric and/or adolescent OCD. All baseline, posttreatment, and change scores with standard deviations… 

Figures and Tables from this paper

Fluoxetine in acute treatment of children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis
TLDR
Fluoxetine is associated with a significantly greater reduction in OCD severity, as measured by the CY-BOCS, NIMH-OC and CGI-S, in children and adolescents, and it is well tolerated inChildren and adolescents.
Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.
  • H. Watson, C. Rees
  • Psychology, Medicine
    Journal of child psychology and psychiatry, and allied disciplines
  • 2008
TLDR
CBT and pharmacotherapy were the only treatments effective beyond control in alleviating OCD symptoms and showed a greater ES than pharmacotherapy, in the first meta-analysis of treatment RCTs for pediatric OCD.
Treatment of Obsessive-Compulsive Disorder
TLDR
There is a paucity of longer-term trials, data on symptom remission and functional improvement, and data on treatment effectiveness in wider clinical practice, and it is hoped that improved understanding of the mechanisms underlying OCD will lead to future advances.
Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders.
TLDR
Predictors of placebo response in internalizing disorders of youths parallel those in adult studies, with the exception of race, and should be considered when designing placebo-controlled trials in youths to enhance findings of true drug-placebo differences.
Evidence-based pharmacotherapy of obsessive-compulsive disorder.
  • N. Fineberg, T. Gale
  • Psychology, Medicine
    The international journal of neuropsychopharmacology
  • 2005
TLDR
Key questions related to OCD pharmacotherapy are reviewed, synthesizing evidence derived from randomized controlled trials, meta-analyses and consensus guidelines, and SSRIs are the preferred option for long-term treatment in most cases.
Efficacy of Antidepressant Medications in Children and Adolescents With Obsessive-Compulsive Disorder: A Systematic Appraisal
  • S. Gentile
  • Psychology, Medicine
    Journal of clinical psychopharmacology
  • 2011
TLDR
Evidence-based information suggests that clomipramine and sertraline, especially for long-term treatments, should be considered as first-choice agents for treating obsessive-compulsive disorder at onset during childhood or adolescence.
Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond
TLDR
The pharmacological evidence-base for the treatment of OCD is becoming increasingly robust, and treatment with SSRIs and clomipramine remains uncontroversial and improvements are sustained over time.
Efficacy of Cognitive-Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder: A Meta-Analysis
TLDR
CBT is efficacious in treating children’s OCD, and a dramatic relief of OCD symptoms after CBT treatment is concluded.
...
...

References

SHOWING 1-10 OF 40 REFERENCES
Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive Disorder
Meta-analytic reviews of placebo-controlled studies for obsessive-compulsive disorder have found that clomipramine is more effective than drugs with more selective actions on serotonin reuptake,
Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
TLDR
Antidepressant drugs are effective in the short-term treatment of patients suffering from OCD; although the increase in improvement rate over placebo was greater for clomipramine than for SSRIs, direct comparison between these drugs showed that they had similar therapeutic efficacy on obsessive–compulsive symptoms.
Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
TLDR
Fluoxetine 20 to 60 mg daily was effective and well tolerated for treatment of OCD in this pediatric population of child and adolescent obsessive-compulsive disorder.
A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome.
TLDR
Fluoxetine therapy was associated with a trend toward some improvement in tic severity, attentional abilities, and social functioning, and the efficacy of fluoxettine in children with TS deserves further larger-scale investigation.
Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.
  • M. Riddle, E. Reeve, J. Walkup
  • Psychology, Medicine
    Journal of the American Academy of Child and Adolescent Psychiatry
  • 2001
TLDR
Fuvoxamine has a rapid onset of action and is well tolerated and efficacious for the short-term treatment of pediatric OCD.
Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder?
TLDR
A 10-week double-blind, placebo-controlled design was employed to investigate the effectiveness of clomipramine (CMI) versus placebo in 16 outpatients with obsessive-compulsive disorder (OCD).
The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
TLDR
Data from a retrospective case-controlled analysis of treatment response to the serotonin reuptake inhibitor fluvoxamine in patients with obsessive-compulsive disorder support the hypothesis that OCD patients with a comorbid chronic tic disorder may be a clinically meaningful subtype.
Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
TLDR
The results suggest that fluoxetine is a generally safe and effective short-term treatment for children with OCD.
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
TLDR
Results of these post hoc analyses show that comorbid illness adversely impacted response to pharmacotherapy with paroxetine in pediatric OCD and significantly increased risk of relapse following withdrawal from treatment.
Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study.
TLDR
Fluoxetine may be useful for the treatment of obsessive-compulsive symptoms in some patients with Tourette's syndrome, but does not appear to be effective for tics.
...
...